Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Collegium Pharmaceutical Inc.
DescriptionExtended‑release, abuse‑deterrent methylphenidate formulated with DETERx tamper resistance technology
Molecular Target Dopamine transporter
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat attention deficit hyperactivity disorder (ADHD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today